Loading institutional data...
Loading institutional data...
Insufficient data to determine institutional momentum.
Data as of Q3 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading insider activity...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Ranked against 39 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LXRX | $659M | — | — | 13.2× | 60.2% | 99.4% | -101% | -46.8% | -31.2% | — | 18 |
| MYGN | $638M | — | — | 0.8× | -1.6% | 69.9% | -44.4% | -99.4% | -75.0% | — | 23 |
| ZVRA | $615M | 7.7× | — | 5.8× | 351% | — | 78.2% | 53.8% | 38.4% | — | 27 |
| CRMD | $599M | 3.8× | 3.0× | 1.9× | 617% | 88.5% | 52.3% | 40.2% | 40.2% | -1.0× | 24 |
| IRWD | $598M | 24.1× | 3.8× | 2.0× | -15.7% | — | 8.1% | -9.2% | -9.2% | -2.2× | 36 |
| TROX | $589M | — | 72.9× | 0.2× | -5.7% | 9.3% | -16.2% | -33.1% | -10.2% | — | 37 |
| ACRS | $587M | — | — | 75.0× | -58.2% | 73.3% | -830% | -63.0% | -63.0% | — | 20 |
| PBYI | $544M | 17.3× | 14.8× | 2.4× | -0.9% | 74.5% | 13.6% | 23.9% | 17.7% | 0.4× | 31 |
| AMRN | $536M | — | — | 2.5× | -6.5% | 56.6% | -18.2% | -8.4% | -8.4% | — | 9 |
| TKNO | $499M | — | — | 12.3× | 7.4% | 33.2% | -42.6% | -25.1% | -21.1% | — | 11 |
| LXFR | $466M | 61.7× | 14.7× | 1.2× | -1.9% | 23.2% | 2.0% | 3.4% | 2.9% | 0.9× | 23 |
| SVA | $465M | — | — | 1.2× | 6.8% | 67.9% | -51.5% | -4.5% | -4.0% | — | 2 |
| AUTL | $421M | — | — | 5.6× | 645% | -27.8% | -381% | -161% | -161% | — | 10 |
| VREOF | $413M | — | 20.7× | 1.5× | 170% | 47.3% | -25.3% | -22.2% | -22.2% | -6.8× | — |
| ASIX | $406M | 8.3× | — | 0.3× | 0.3% | 10.8% | 3.2% | 6.0% | 6.0% | — | 65 |
| VHI | $396M | — | — | 0.2× | -1.3% | 14.2% | -2.8% | -5.6% | -5.6% | — | 15 |
| TLRY | $390M | — | — | 0.4× | 11.5% | 28.4% | -13.3% | -7.5% | -7.0% | — | 55 |
| EBS | $370M | 7.8× | 3.8× | 0.5× | -28.8% | 56.1% | 7.1% | 10.1% | 4.8% | 1.9× | 29 |
| NL | $342M | — | 16.1× | 2.2× | 8.5% | 30.4% | -23.9% | -10.5% | -10.5% | -7.7× | 13 |
| ASPI | $327M | — | — | 13.7× | 476% | 14.3% | -670% | -78.3% | -77.5% | — | 24 |
| OEC | $313M | — | 7.6× | 0.2× | -3.8% | 19.9% | -3.9% | -18.2% | -5.2% | 5.7× | 24 |
| ALTO | $283M | 22.8× | 10.4× | 0.3× | -4.9% | 3.8% | 1.5% | 5.4% | 4.1% | 1.7× | 16 |
| USNA | $265M | 24.7× | 1.5× | 0.3× | 8.3% | 78.3% | 1.2% | 2.0% | 2.0% | -2.3× | 18 |
| QTTB | $264M | 3.7× | 12.5× | 4.9× | — | — | 55.5% | 71.0% | 71.0% | -2.8× | 3 |
| FF | $250M | — | — | 2.6× | -60.7% | -41.2% | -51.6% | -30.4% | -30.4% | — | 18 |
Peers = companies sharing ASIX's sector (Plastic Materials, Synth Resins & Nonvulcan Elastomers) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
What the company returns to shareholders — and whether it's covered by cash.
The dividend exceeds free cash flow (268%) — funded from the balance sheet or debt, a red flag if it persists. Last year: $17.2M dividends + $1.7M buybacks = $18.8M returned on $6.4M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: 6%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
EOD close · as of 2026-10-30
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.52B 100.0% | $1.52B 100.0% | $1.53B 100.0% | $1.95B 100.0% | $1.68B 100.0% | $1.16B 100.0% | $1.30B 100.0% | $1.51B 100.0% | $1.48B 100.0% | $1.19B 100.0% |
| Cost of Revenue | $1.36B 89.2% | $1.36B 89.9% | $1.37B 89.2% | $1.63B 83.8% | $1.41B 83.7% | $1.02B 88.4% | $1.16B 89.6% | $1.34B 88.5% | $1.25B 84.6% | $1.08B 90.9% |
| Cost of Products | — | — | — | — | — | — | — | — | $1.25B 84.7% | $1.08B 91.0% |
| Gross Profit | — | — | — | — | — | $133.7M 11.6% | $135.5M 10.4% | $174.5M 11.5% | $227.1M 15.4% | $107.6M 9.0% |
| Research & Development | $8.7M 0.6% | $8.8M 0.6% | $9.8M 0.6% | $12.5M 0.6% | $14.0M 0.8% | $11.8M 1.0% | $13.9M 1.1% | $14.8M 1.0% | $12.9M 0.9% | $13.8M 1.2% |
| Selling, General & Admin | $104.8M 6.9% | $94.0M 6.2% | $95.5M 6.2% | $87.7M 4.5% | $83.0M 4.9% | $70.9M 6.1% | $75.4M 5.8% | $81.2M 5.4% | $72.7M 4.9% | $53.7M 4.5% |
| Other Income (Expense), net | $2.7M 0.2% | -$2.0M -0.1% | $7.2M 0.5% | $1.8M 0.1% | -$998K -0.1% | -$53K -0.0% | -$1.3M -0.1% | -$3K -0.0% | -$9.8M -0.7% | -$417K -0.0% |
| Pretax Income | $54.4M 3.6% | $45.6M 3.0% | $69.2M 4.5% | $225.8M 11.6% | $185.1M 11.0% | $55.0M 4.8% | $53.3M 4.1% | $85.8M 5.7% | $144.6M 9.8% | $53.8M 4.5% |
| Income Tax Expense | $5.1M 0.3% | $1.4M 0.1% | $14.6M 1.0% | $53.9M 2.8% | $45.3M 2.7% | $9.0M 0.8% | $12.0M 0.9% | $19.5M 1.3% | -$2.1M -0.1% | $19.6M 1.6% |
| Net Income | $49.3M 3.2% | $44.1M 2.9% | $54.6M 3.6% | $171.9M 8.8% | $139.8M 8.3% | $46.1M 4.0% | $41.3M 3.2% | $66.2M 4.4% | $146.7M 9.9% | $34.1M 2.9% |
| Per Share | ||||||||||
| EPS (Basic) | $1.83 | $1.65 | $2.00 | $6.15 | $4.97 | $1.64 | $1.47 | $2.20 | $4.81 | $1.12 |
| EPS (Diluted) | $1.80 | $1.62 | $1.95 | $5.92 | $4.81 | $1.64 | $1.43 | $2.14 | $4.72 | $1.12 |
| Weighted Avg Shares (Basic) | 26.9M | 26.8M | 27.3M | 28.0M | 28.2M | 28.0M | 28.1M | 30.2M | 30.5M | 30.5M |
| Weighted Avg Shares (Diluted) | 27.3M | 27.3M | 28.0M | 29.0M | 29.0M | 28.2M | 28.9M | 31.0M | 31.1M | 30.5M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Solve the discounted cash flow backwards, then stress-test the assumptions.
Average free cash flow across the last 3 positive fiscal years (FY2023, FY2024, FY2025). Smooths the cycle. Stock compensation is NOT charged — it is added back inside operating cash flow.
To be worth $15.36 today, the market must believe free cash flow compounds 13.4%/yr for a decade (off $6.1M on the 3-yr avg basis).
On the basis (-$1.6M) the requirement is off the scale. Shares issued to employees are added back in operating cash flow, so this basis treats them as free.
The market's 13.4% is more optimistic than its 9-yr track record.
Default is 6.4% — this company's computed cost of capital (computed WACC), the same rate the Analysis tab discounts at.
2-stage DCF · 0.03B shares (market data) · net debt -$19.8M
mean 65.5% · volatility σ 206% · implied rate exceeded in 5/8 yrs
Central path = implied 13.4%/yr growth; shaded band = ±1σ (206%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $31.0M covers the $0 due within a year 30985000.0× over. Scheduled principal only (excludes interest & revolver draws). As of 2022-12-31 (10-K).
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest expense isn't separately reported — often netted into “other income (expense), net.”
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Last reported position per insider, carried forward. Steps can be a holding disclosed for the first time rather than a trade.
| Date | Insider | What it was | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-06 | Williams Patrick Director | Grant | 785 | $16.70 | $13k |
| 2026-06-30 | Williams Patrick Director | Grant | 660 | $19.88 | $13k |
| 2026-06-22 | Roberts Daryl Director | Grant | 6,207 | $0.00 | $0 |
| 2026-06-22 | Lovett Gena C Director | Grant | 6,207 | $0.00 | $0 |
| 2026-06-22 | Karran Todd D. Director |
Every row is classified by what it MEANT, not by its SEC code. A code is not a meaning: code P (“purchase”) also covers dividend reinvestment and employee stock purchase plans, and code S (“sale”) also covers 10b5-1 plan sales scheduled months earlier and option exercises sold the same day.
Across 30 days of all filings, $5.08bn of insider selling contained $3.50bn of plan sales and $0.46bn of exercise-and-sell. Only 29% was discretionary. Reading an unclassified feed badly overstates how much insiders decided.
Buys and sales are counted separately and never netted. They are different decisions by different people; a company where one officer bought while another sold is not “neutral”.
The holding line carries each insider's last reported position forward, so it shows the total held rather than a sawtooth of whoever traded that day. It covers only insiders who filed in the window.
“Filed late” counts calendar days past the two-business-day deadline with five days' grace, so a Thursday or Friday trade crossing a weekend is never flagged. It describes the company's filing discipline, not the trade.
Insider activity is descriptive. Nothing here is investment advice.
| Grant |
| 6,207 |
| $0.00 |
| $0 |
| 2026-06-22 | Bird Jeffrey J. Director | Grant | 6,207 | $0.00 | $0 |
| 2026-06-22 | Spurlin Sharon Director | Grant | 6,207 | $0.00 | $0 |
| 2026-06-22 | Williams Patrick Director | Grant | 6,207 | $0.00 | $0 |
| 2026-06-22 | Newman Donald P Director | Grant | 6,207 | $0.00 | $0 |
| 2026-06-22 | O'Brien Dana C. Director | Grant | 6,207 | $0.00 | $0 |
| 2026-04-27 | 2 co-filers SVP, CFO | Grant | 19,019 | $23.66 | $450k |
| 2026-04-27 | 2 co-filers SVP, CFO | Grant | 19,019 | $23.66 | $450k |
| 2026-03-31 | Williams Patrick Director | Grant | 537 | $24.40 | $13k |
| 2026-03-24 | Ryan Rachael E VP, Controller | Tax withholding | 2,074 | $22.02 | $46k |
| 2026-02-28 | Slieter Kelly SVP, Chief HR Officer | Tax withholding | 5,424 | $17.47 | $95k |
| 2026-02-28 | Kintiroglou Achilles B. SVP, General Counsel | Tax withholding | 8,008 | $17.47 | $140k |
| 2026-02-28 | Kane Erin N Chief Executive Officer | Tax withholding | 33,642 | $17.47 | $588k |
| 2026-02-28 | Gramm Christopher VP and Interim CFO | Tax withholding | 2,624 | $17.47 | $46k |
| 2026-02-26 | Ryan Rachael E VP, Controller | Grant | 5,621 | $17.79 | $100k |
| 2026-02-26 | Slieter Kelly SVP, Chief HR Officer | Grant | 22,485 | $17.79 | $400k |
| 2026-02-26 | Kintiroglou Achilles B. SVP, General Counsel | Grant | 28,106 | $17.79 | $500k |
| 2026-02-26 | Kane Erin N Chief Executive Officer | Grant | 111,298 | $17.79 | $2.0m |
| 2026-02-26 | Gramm Christopher VP and Interim CFO | Grant | 21,079 | $17.79 | $375k |
| 2025-12-15 | Williams Patrick Director | Grant | 821 | $15.97 | $13k |
| 2025-12-15 | Newman Donald P Director | Grant | 1,721 | $15.97 | $27k |
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-10-30
Where each multiple sits in its own 10-yr range · 7th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 10-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE 6% against ROIC 6% — 0% of the return on equity comes from leverage and buybacks rather than from the operating business.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
Operating leverage needs meaningful revenue change.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 88.5 | 89.6 | 88.4 | 83.7 | 83.8 | 89.2 | 89.9 | 89.2 |
| Gross Profit | 11.5 | 10.4 | 11.6 | — | — | — | — | — |
| R&D | 1.0 | 1.1 | 1.0 | 0.8 | 0.6 | 0.6 | 0.6 | 0.6 |
| SG&A | 5.4 | 5.8 | 6.1 | 4.9 | 4.5 | 6.2 | 6.2 | 6.9 |
| Income Tax | 1.3 | 0.9 | 0.8 | 2.7 | 2.8 | 1.0 | 0.1 | 0.3 |
| Net Income | 4.4 | 3.2 | 4.0 | 8.3 | 8.8 | 3.6 | 2.9 | 3.2 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on ASIX: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
Earns -1.59pts against its cost of capital — capital is being consumed, not created.
| Period | ROIC | Cost of capital | Spread |
|---|---|---|---|
| FY2019 | 5.8% | 6.4% (today's — no rate published for this year) | -0.6pts |
| FY2020 | 5.9% | 6.4% (today's — no rate published for this year) | -0.5pts |
| FY2021 | 18.9% | 6.4% (today's — no rate published for this year) | 12.5pts |
| FY2022 | 20.5% | 6.4% (today's — no rate published for this year) | 14.1pts |
| FY2023 | 6.6% | 6.4% (today's — no rate published for this year) | 0.2pts |
| FY2024 | 4.5% | 6.4% (today's — no rate published for this year) | -1.8pts |
| FY2025 | 4.7% | 6.4% (today's — no rate published for this year) | -1.7pts |
| Now | 6.0% | 6.4% | -0.3pts |
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2016 | 9.0% | 4.5% | 2.9% |
| FY2017 | 15.4% | 10.5% | 9.9% |
| FY2018 | 11.5% | 5.7% | 4.4% |
| FY2019 | 10.4% | 4.2% | 3.2% |
| FY2020 | 11.6% | 4.8% | 4.0% |
| FY2021 | 16.3% | 11.0% | 8.3% |
| FY2022 | 16.2% | 11.5% | 8.8% |
| FY2023 | 10.8% | 4.0% | 3.6% |
| FY2024 | 10.1% | 3.1% | 2.9% |
| FY2025 | 10.8% | 3.4% | 3.2% |
Return on equity (6%) and return on invested capital (6%) are within a couple of points in FY2025, so the headline return is the operating return — there is no meaningful leverage effect to strip out.
$56M of goodwill — 6% of invested capital. The gap is what was paid above the fair value of what was bought; it is real capital shareholders provided, so neither bar is the whole answer.
The spread is -1.59pts and would invert under a ±2% move in WACC, so the verdict rests on the cost-of-capital assumption rather than on the business.
Free cash flow has fallen short of reported profit in 3 of the last three years.
Reported free cash flow is $6M; after share-based compensation it is -$403,000. The difference is a real cost that the cash flow statement adds back.
Debt is present but there is no positive EBITDA or no reported interest expense, so coverage cannot be measured.
This schedule comes from a filing dated 2022-12-31, 1399 days old. Maturities are shown relative to that date, not to today.
Ladder as of 2022-12-31 (10-K); cash from the 2022-12-31 balance sheet; FCF from FY2022.
Balance sheet at 2022-12-31. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
No material counter-signal in the checked set: net debt / EBITDA, interest coverage, stressed coverage, maturity schedule vs cash and one year of FCF, liquidity ratios.
Missing from our data, so excluded from this answer: ebitda, interest_expense.
At $15.03, free cash flow must compound 17.63%/yr for 10 years. It has no positive compounding record to compare against.
| Fiscal year | FCF growth | Price requires |
|---|---|---|
| FY2021 | 460.1% | 17.6% |
| FY2022 | 13.6% | 17.6% |
| FY2023 | −94.5% | 17.6% |
| FY2024 | −83.4% | 17.6% |
| FY2025 | 279.5% | 17.6% |
The percentile ranks the FISCAL-YEAR point, because the distribution behind each strip is built from fiscal-year closes — ranking a TTM figure inside it would compare two different bases. TTM basis: TTM.
The implied rate has been matched or beaten in 2 of the last 5 years.
| Step | Amount | Running total |
|---|---|---|
| Net income | $49M | $49M |
| Share-based comp | $7M | $56M |
| Other non-cash & working capital | $67M | $123M |
| Operating cash flow | $123M | $123M |
| Capex | −$116M | $6M |
| Free cash flow | $6M | $6M |
| FCF after SBC | −$403,000 | −$403,000 |
| Fiscal year | Revenue growth | Receivables growth | Gap |
|---|---|---|---|
| FY2020 | -10.8% | not reported | not reported |
| FY2021 | 45.5% | not reported | not reported |
| FY2022 | 15.5% | not reported | not reported |
| FY2023 | -21.2% | not reported | not reported |
| FY2024 | -1.1% | not reported | not reported |
| FY2025 | 0.3% | not reported | not reported |
| Fiscal year | Accruals / assets |
|---|---|
| FY2019 | -6.4 percent |
| FY2020 | -5.2 percent |
| FY2021 | -6.0 percent |
| FY2022 | -6.8 percent |
| FY2023 | -4.2 percent |
| FY2024 | -5.7 percent |
| FY2025 | -4.3 percent |
SBC is added back inside operating cash flow, so reported free cash flow treats shares issued to employees as free. Percent of revenue says how expensive the payroll is; percent of operating cash flow says how much of the cash exists only because the charge was added back. The buyback offset is buybacks over SBC — below 1.0 the repurchase does not cover the shares issued.
Figures are the latest fiscal year (FY2025) from the company's own filings, not a trailing-twelve-month window — Q2 reads fiscal years throughout so the cash-conversion ratios and these share one basis. A blank is a line the filer did not report; it is never read as zero.